Estimated pulse wave velocity and progression to advanced cardiovascular–kidney–metabolic syndrome: a population-based longitudinal study with supportive external cross-sectional evidence

Wenjiao Zhang, Wenbo Yang, Yirui Xu, Heze Fan, Hao Yuan, Qi Kang, Shumei Zhang, Peiyao Zhang, Eerwei Hu, Xueying Feng, Lijun Wang, Zuyi Yuan, Juan Zhou

Open source

DOI
10.3389/fcvm.2026.1875961
Published
2026-07-08
Container
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.1875961,
  title = {Estimated pulse wave velocity and progression to advanced cardiovascular–kidney–metabolic syndrome: a population-based longitudinal study with supportive external cross-sectional evidence},
  author = {Wenjiao Zhang and Wenbo Yang and Yirui Xu and Heze Fan and Hao Yuan and Qi Kang and Shumei Zhang and Peiyao Zhang and Eerwei Hu and Xueying Feng and Lijun Wang and Zuyi Yuan and Juan Zhou},
  year = {2026},
  journal = {Frontiers in Cardiovascular Medicine},
  doi = {10.3389/fcvm.2026.1875961},
  url = {https://doi.org/10.3389/fcvm.2026.1875961}
}

RIS

TY  - JOUR
TI  - Estimated pulse wave velocity and progression to advanced cardiovascular–kidney–metabolic syndrome: a population-based longitudinal study with supportive external cross-sectional evidence
AU  - Wenjiao Zhang
AU  - Wenbo Yang
AU  - Yirui Xu
AU  - Heze Fan
AU  - Hao Yuan
AU  - Qi Kang
AU  - Shumei Zhang
AU  - Peiyao Zhang
AU  - Eerwei Hu
AU  - Xueying Feng
AU  - Lijun Wang
AU  - Zuyi Yuan
AU  - Juan Zhou
PY  - 2026
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1875961
UR  - https://doi.org/10.3389/fcvm.2026.1875961
ER  - 

APA

Zhang, W., Yang, W., Xu, Y., Fan, H., Yuan, H., Kang, Q., Zhang, S., Zhang, P., Hu, E., Feng, X., Wang, L., Yuan, Z., & Zhou, J. (2026). Estimated pulse wave velocity and progression to advanced cardiovascular–kidney–metabolic syndrome: a population-based longitudinal study with supportive external cross-sectional evidence. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2026.1875961

Source records